Downregulation of the Proinflammatory State of Circulating Mononuclear Cells by Short-Term Treatment with Pioglitazone in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease

Figure 1

Changes in plasma concentrations of MMP-9, MCP-1, hsCRP, and glucose during the four-week observation period.

(a)

(b)

(c)

(d)